Salugan, Nina H.

HRN: 26-48-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/23/2026
06/30/2026
IVT
4.5g
Q8
Decubitus Ulcer
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines